You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sulfonylurea

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthcare Cost and Resource Utilization in Type 2 Diabetes and

Withdrawn
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Ridgefield, Connecticut
    Boehringer Ingelheim Pharmaceuticals Inc
May 30, 2022

KCNJ11-related Intermediate Developmental Delay, Epilepsy and

Recruiting
  • Neurodevelopmental Disorders
  • +5 more
  • Sulfonylurea
  • Chicago, Illinois
  • +3 more
Feb 20, 2023

Second-line Therapies for Type 2 Diabetes and Moderate

Enrolling by invitation
  • Type 2 Diabetes
  • Cardiac Disease
  • Glucagon like peptide 1 receptor agonist
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic Rochester
Jan 26, 2022

Type 2 Diabetes Trial in Dundee (Sulfonylurea, DPP4 Inhibitor)

Completed
  • Type 2 Diabetes
  • Sulfonylurea
  • DPP4 Inhibitor
  • Dundee, United Kingdom
    Ninewells Hospital and Medical School
Mar 3, 2021

Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Placebo, Metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Sotagliflozin (SAR439954)
  • +3 more
  • Litchfield Park, Arizona
  • +75 more
Apr 16, 2021

Permanent Neonatal Diabetes Trial in Bergen (Sulfonylurea)

Unknown status
  • Permanent Neonatal Diabetes Mellitus
  • Sulfonylurea
  • Bergen, Norway
    Haukeland University Hospital
Feb 10, 2020

Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1, Childhood Diabetes Trial in Bergen

Unknown status
  • Maturity-Onset Diabetes of the Young, Type 3
  • +3 more
  • Sulfonylurea
  • Bergen, Norway
    Department of Pediatrics and Adolescents, Haukeland University H
Jan 21, 2020

Replication of the CARMELINA Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
Jan 28, 2020

Replication of the TECOS Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
Dec 30, 2019

Replication of SAVOR-TIMI Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
Dec 30, 2019

Type 2 Diabetes Trial in Japan (ipragliflozin, Placebo, Sulfonylurea)

Completed
  • Type 2 Diabetes Mellitus
  • ipragliflozin
  • +2 more
  • Chubu, Japan
  • +6 more
Apr 29, 2019

Type 2 Diabetes, Proteinuria Trial (Dipeptidyl Peptidase 4 Inhibitor, Sulfonylurea)

Completed
  • Type 2 Diabetes Mellitus
  • Proteinuria
  • Dipeptidyl Peptidase 4 Inhibitor
  • Sulfonylurea
  • (no location specified)
Jun 12, 2019

Type 2 Diabetes Trial (Sitagliptin, Dapagliflozin, Metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • (no location specified)
Oct 22, 2018

Type II Diabetes Trial in Korea, Republic of (Pioglitazone, Metformin, Sulfonylurea)

Completed
Has Results
  • Type II Diabetes Mellitus
  • Chagwon, Korea, Republic of
  • +8 more
Aug 13, 2018

Diabetes, Type 2 Trial in Worldwide (LY2409021, Sitagliptin, Placebo)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +32 more
Sep 25, 2019

Type 2 Diabetes Trial in Turkey (INSULIN GLARGINE (U300), metformin, sulfonylurea)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (U300)
  • +8 more
  • Turkey, Turkey
    (unnamed)
Jan 10, 2019

Permanent Neonatal Diabetes Trial in Bergen (Sulfonylurea)

Completed
  • Permanent Neonatal Diabetes Mellitus
  • Sulfonylurea
  • Bergen, Norway
    Haukeland University Hospital
Sep 29, 2017

Diabetes, Diabetes, Type 2 Trial in Tokyo (sulfonylurea, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Jan 25, 2017

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +4 more
  • Bridgewater, New Jersey
  • +15 more
Oct 21, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +4 more
  • Tokyo, Japan
  • +3 more
Aug 18, 2016

Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Lixisenatide (AVE0010)
  • +4 more
  • Beijing, China
  • +34 more
Aug 18, 2016

Diabetes Trial in Japan (Albiglutide, Sulfonylurea, Biguanide)

Completed
Has Results
  • Diabetes Mellitus
  • Aichi, Japan
  • +48 more
Mar 30, 2017

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Sulfonylurea, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Miranda, New South Wales, Australia
  • +446 more
Mar 21, 2017

Diabetes, Type 2 Trial in Hellerup, Copenhagen (Sulfonylurea)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Sulfonylurea
  • Hellerup, Copenhagen, Denmark
    Department of Internal Medicine, Gentofte University Hospital
Jun 23, 2015

Type 2 Diabetes Trial in United States (50 mg PB1023, 70 mg PB1023, 100 mg PB1023)

Completed
  • Type 2 Diabetes Mellitus
  • 50 mg PB1023
  • +8 more
  • Anniston, Alabama
  • +92 more
Nov 5, 2015